Furthermore, a direct comparison of OCA with the FXR agonist EDP-305 in Mdr2-/- mice showed that EDP-305 more potently improved hepatic fibrosis and downregulated activation of HSCs.38 Here, NR1H4 is linked to Hepatic fibrosis.